Ocular Therapeutix
OCUL
OCUL
196 hedge funds and large institutions have $1.01B invested in Ocular Therapeutix in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 59 increasing their positions, 58 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 58
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
12% less capital invested
Capital invested by funds: $1.14B → $1.01B (-$136M)
Holders
196
Holding in Top 10
10
Calls
$5.14M
Puts
$2.16M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$10.7M | |
| 3 | +$9.63M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$6.21M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$4.04M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$8.8M | |
| 3 | -$7.28M | |
| 4 |
Millennium Management
New York
|
-$3.82M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.76M |
